GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

The Telangana High Court has delivered a judgment against the Income Tax Department in two writ petitions filed by TSI ...